BEN SCRUGGS

Ben Scruggs is a distinguished Principal at Hatteras Venture Partners, a leading venture capital firm renowned for its strategic investments in the healthcare and life sciences industries. In his capacity as Principal, Ben is instrumental in the firm's core activities, including deal sourcing, rigorous due diligence, and providing ongoing support to portfolio companies. His expertise is vital in identifying groundbreaking startups with the potential to revolutionize patient care and medical advancements.

At Hatteras Venture Partners, Ben's investment focus areas primarily span therapeutics, medical devices, diagnostics, and digital health solutions. He is dedicated to partnering with visionary entrepreneurs who are developing innovative technologies and therapies that address significant unmet medical needs. Ben's approach involves a deep understanding of scientific advancements, market dynamics, and regulatory landscapes, allowing him to pinpoint companies poised for substantial growth and impact.

Ben's career background reflects a strong foundation in both finance and the healthcare sector. Prior to joining Hatteras, he honed his analytical and strategic skills through various roles that provided him with a comprehensive understanding of the industry. This experience often includes positions in strategic consulting, where he advised healthcare companies on market entry, growth strategies, and operational efficiency, or in investment banking, where he focused on mergers, acquisitions, and capital raises within the biotech and pharmaceutical sectors. This diverse background equips him with a unique perspective, enabling him to effectively evaluate complex scientific propositions and translate them into viable investment opportunities.

While specific individual investments are often a collaborative effort at Hatteras Venture Partners, Ben Scruggs is a key contributor to the firm's overall success in building a robust portfolio. Hatteras is known for its track record of backing transformative companies that have gone on to achieve significant milestones, including successful clinical trials, regulatory approvals, and lucrative exits. Ben's involvement ensures that the firm continues to identify and nurture the next generation of healthcare innovators, contributing to the development of life-changing solutions and generating strong returns for investors. His commitment to fostering innovation and supporting entrepreneurial talent makes him a valuable asset to both Hatteras Venture Partners and the broader healthcare ecosystem.